Chie Tamai

524 total citations
8 papers, 424 citations indexed

About

Chie Tamai is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chie Tamai has authored 8 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chie Tamai's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Chie Tamai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Chie Tamai collaborates with scholars based in Japan, Sweden and Switzerland. Chie Tamai's co-authors include Ryu Ishihara, Natsuko Kawada, Tsukasa Kawaguchi, Kazuho Imanaka, Takashi Matsunaga, Yasuhiko Tomita, Kunihito Gotoh, Terumasa Yamada, Yoji Takeuchi and Hiroyasu Iishi and has published in prestigious journals such as The American Journal of Gastroenterology, Cancer Science and Journal of Gastroenterology.

In The Last Decade

Chie Tamai

8 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chie Tamai Japan 7 194 184 164 146 115 8 424
Enrique Norero Chile 10 157 0.8× 138 0.8× 124 0.8× 34 0.2× 89 0.8× 25 403
Donald J. Lazas United States 5 149 0.8× 266 1.4× 415 2.5× 73 0.5× 205 1.8× 8 729
S Schulte Germany 10 98 0.5× 102 0.6× 168 1.0× 121 0.8× 16 0.1× 17 312
H. Hokotate Japan 7 66 0.3× 170 0.9× 158 1.0× 213 1.5× 15 0.1× 16 355
Takayuki Fukuhara Japan 14 40 0.2× 219 1.2× 134 0.8× 254 1.7× 21 0.2× 30 402
Chuan‐Pau Siauw Taiwan 9 137 0.7× 77 0.4× 146 0.9× 90 0.6× 26 0.2× 21 280
Wei‐Fan Hsu Taiwan 12 66 0.3× 193 1.0× 90 0.5× 220 1.5× 18 0.2× 45 365
Naoyuki Katada Japan 11 54 0.3× 78 0.4× 189 1.2× 73 0.5× 24 0.2× 30 304
Cheng‐Chung Tsai Taiwan 9 90 0.5× 104 0.6× 170 1.0× 179 1.2× 32 0.3× 16 322
Martina Felder Italy 10 56 0.3× 364 2.0× 310 1.9× 355 2.4× 34 0.3× 18 588

Countries citing papers authored by Chie Tamai

Since Specialization
Citations

This map shows the geographic impact of Chie Tamai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Tamai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Tamai more than expected).

Fields of papers citing papers by Chie Tamai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Tamai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Tamai. The network helps show where Chie Tamai may publish in the future.

Co-authorship network of co-authors of Chie Tamai

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Tamai. A scholar is included among the top collaborators of Chie Tamai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Tamai. Chie Tamai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hagihara, Atsushi, Masafumi Ikeda, Hideki Ueno, et al.. (2014). Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma. Cancer Science. 105(3). 354–358. 9 indexed citations
2.
Ohkawa, Kazuyoshi, Kazuho Imanaka, Mitsuru Sakakibara, et al.. (2014). Factors related to shift from hepatic borderline lesion to overt HCC diagnosed by CT.. PubMed. 61(134). 1680–7. 6 indexed citations
3.
Kawaguchi, Tsukasa, Kazuyoshi Ohkawa, Kazuho Imanaka, et al.. (2011). Lipiodol Accumulation and Transarterial Chemoembolization Efficacy for HCC Patients. Hepatogastroenterology. 59(113). 219–23. 12 indexed citations
5.
Inoue, Takuya, Noriya Uedo, Ryu Ishihara, et al.. (2009). Autofluorescence imaging videoendoscopy in the diagnosis of chronic atrophic fundal gastritis. Journal of Gastroenterology. 45(1). 45–51. 30 indexed citations
6.
Kawada, Natsuko, Kazuho Imanaka, Tsukasa Kawaguchi, et al.. (2009). Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. Journal of Gastroenterology. 44(12). 1190–1194. 166 indexed citations
7.
Uedo, Noriya, Yoji Takeuchi, Takuya Yamada, et al.. (2007). Effect of a Proton Pump Inhibitor or an H2-Receptor Antagonist on Prevention of Bleeding From Ulcer After Endoscopic Submucosal Dissection of Early Gastric Cancer: A Prospective Randomized Controlled Trial. The American Journal of Gastroenterology. 102(8). 1610–1616. 169 indexed citations
8.
Suzuki, Rei, Toshiya Shibata, Takahiro Niinobu, et al.. (2000). [Three long surviving patients with gastric cancer metastasizing to the liver under interdisciplinary therapy].. PubMed. 27(12). 1997–2000. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026